JP2016505534A5 - - Google Patents

Download PDF

Info

Publication number
JP2016505534A5
JP2016505534A5 JP2015543399A JP2015543399A JP2016505534A5 JP 2016505534 A5 JP2016505534 A5 JP 2016505534A5 JP 2015543399 A JP2015543399 A JP 2015543399A JP 2015543399 A JP2015543399 A JP 2015543399A JP 2016505534 A5 JP2016505534 A5 JP 2016505534A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015543399A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016505534A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/074012 external-priority patent/WO2014079787A1/en
Publication of JP2016505534A publication Critical patent/JP2016505534A/ja
Publication of JP2016505534A5 publication Critical patent/JP2016505534A5/ja
Pending legal-status Critical Current

Links

JP2015543399A 2012-11-20 2013-11-18 置換1,6−ナフチリジン Pending JP2016505534A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12193311.3 2012-11-20
EP12193311 2012-11-20
PCT/EP2013/074012 WO2014079787A1 (en) 2012-11-20 2013-11-18 Substituted 1,6-naphthyridines

Publications (2)

Publication Number Publication Date
JP2016505534A JP2016505534A (ja) 2016-02-25
JP2016505534A5 true JP2016505534A5 (2) 2017-01-05

Family

ID=47189816

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015543399A Pending JP2016505534A (ja) 2012-11-20 2013-11-18 置換1,6−ナフチリジン

Country Status (13)

Country Link
US (1) US9657014B2 (2)
EP (1) EP2922540A1 (2)
JP (1) JP2016505534A (2)
KR (1) KR20150085538A (2)
CN (1) CN104812387A (2)
AR (1) AR093519A1 (2)
BR (1) BR112015011094A2 (2)
CA (1) CA2890685A1 (2)
HK (1) HK1207317A1 (2)
MX (1) MX2015006364A (2)
RU (1) RU2015120217A (2)
TW (1) TW201425312A (2)
WO (1) WO2014079787A1 (2)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI529171B (zh) 2013-07-29 2016-04-11 赫孚孟拉羅股份公司 1,7-萘啶衍生物
JP2017522324A (ja) * 2014-07-17 2017-08-10 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung 新規ナフチリジン及びイソキノリンならびにcdk8/19阻害剤としてのその使用
EP3256217A1 (en) * 2015-02-11 2017-12-20 Basilea Pharmaceutica International AG Substituted mono- and polyazanaphthalene derivatives and their use
AU2016236669B2 (en) 2015-03-24 2018-11-08 Shanghai Yingli Pharmaceutical Co., Ltd Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof
BR112018008630A2 (pt) * 2015-11-06 2018-10-30 Neurocrine Biosciences Inc derivados de n-[2-(1-benzilpiperidin-4-il)etil]-4-(pirazin-2-il)-piperazina-1-carboxamida, seus usos, composição farmacêutica
EA039638B1 (ru) * 2016-01-06 2022-02-21 Нейрокрин Байосайенсиз, Инк. Антагонисты мускаринового рецептора 4 и способы их применения
EP3591040A4 (en) 2017-03-03 2020-11-11 Kyoto University METHOD OF PRODUCTION OF PANCREATIC PROGENITOR CELLS
BR112021012950A2 (pt) 2019-01-03 2021-09-14 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Métodos e materiais para aumentar os níveis de polipeptídeo do fator de transcrição eb
US12486250B2 (en) 2019-12-06 2025-12-02 Neurocrine Biosciences, Inc. Muscarinic receptor 4 antagonists and methods of use
JP2024508761A (ja) * 2020-12-18 2024-02-28 ザ スクリプス リサーチ インスティテュート 神経変性、変性及び代謝性障害の処置のための化合物並びにその使用
WO2025252732A1 (en) * 2024-06-04 2025-12-11 Syngenta Crop Protection Ag Nitrogen-containing 6-membered bicyclic derivatives with microbiocidal activity

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9605437D0 (en) 1996-03-15 1996-05-15 Iaf Biochem Int Cytomegalovirus inhibiting compounds
CN1283995A (zh) * 1997-12-11 2001-02-14 生化制药有限公司 抗病毒化合物
AU2002218902A1 (en) 2000-12-27 2002-07-08 Shire Biochem Inc. Macrocyclic anti-viral compounds
US7282506B2 (en) * 2004-08-03 2007-10-16 Serenex, Inc. 2,8-disubstituted naphthyridine derivatives
FR2904317A1 (fr) 2006-07-27 2008-02-01 Inst Nat Sante Rech Med Analogues d'halogenobenzamides marques a titre de radiopharmaceutiques
US20080242694A1 (en) 2006-09-18 2008-10-02 D Sidocky Neil R Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith
WO2008046072A2 (en) 2006-10-13 2008-04-17 The Board Of Regents Of The University Of Texas System Chemical inducers of neurogenesis
CN102325754B (zh) * 2009-01-19 2014-03-12 第一三共株式会社 含杂原子的环状化合物
AU2010221417A1 (en) * 2009-03-02 2011-09-22 Sirtris Pharmaceuticals, Inc. 8-substituted quinolines and related analogs as sirtuin modulators
KR20120006016A (ko) * 2009-04-06 2012-01-17 다이이찌 산쿄 가부시키가이샤 치환 페닐기를 갖는 고리형 화합물
CA2804161A1 (en) 2010-07-07 2012-01-12 Board Of Regents Of The University Of Texas System Pro-neurogenic compounds
JP2012036168A (ja) 2010-07-15 2012-02-23 Daiichi Sankyo Co Ltd ヘテロ原子を有する環状化合物を含有する医薬組成物

Similar Documents

Publication Publication Date Title
JP2014026276A5 (2)
JP2014026275A5 (2)
JP2014026274A5 (2)
JP2015511482A5 (2)
JP2015508051A5 (2)
JP2013212124A5 (2)
JP2015509368A5 (2)
JP2014189812A5 (2)
JP2016501900A5 (2)
JP2013241444A5 (2)
JP2014503786A5 (2)
JP2014156601A5 (2)
JP2015107586A5 (2)
JP2015500269A5 (2)
JP2014220238A5 (2)
JP2015077594A5 (2)
JP2016505534A5 (2)
JP2016526891A5 (2)
JP2015007765A5 (2)
JP2014520787A5 (2)
JP2015518513A5 (2)
JP2014520786A5 (2)
JP2014531903A5 (2)
JP2014534151A5 (2)
JP2014205658A5 (2)